[HTML][HTML] Current treatment options for COVID-19 associated mucormycosis: present status and future perspectives
Y Madhavan, KV Sai, DK Shanmugam… - Journal of Clinical …, 2022 - mdpi.com
Mucormycosis has become increasingly associated with COVID-19, leading to the use of the
term “COVID-19 associated mucormycosis (CAM)”. Treatment of CAM is challenging due to …
term “COVID-19 associated mucormycosis (CAM)”. Treatment of CAM is challenging due to …
[PDF][PDF] Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives
Y Madhavan, KV Sai, DK Shanmugam… - J. Clin …, 2022 - pdfs.semanticscholar.org
Mucormycosis has become increasingly associated with COVID-19, leading to the use of the
term “COVID-19 associated mucormycosis (CAM)”. Treatment of CAM is challenging due to …
term “COVID-19 associated mucormycosis (CAM)”. Treatment of CAM is challenging due to …
Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives.
Y Madhavan, KV Sai, DK Shanmugam… - Journal of Clinical …, 2022 - europepmc.org
Mucormycosis has become increasingly associated with COVID-19, leading to the use of the
term “COVID-19 associated mucormycosis (CAM)”. Treatment of CAM is challenging due to …
term “COVID-19 associated mucormycosis (CAM)”. Treatment of CAM is challenging due to …
Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives
Y Madhavan, KV Sai, DK Shanmugam… - Journal of Clinical …, 2022 - search.proquest.com
Mucormycosis has become increasingly associated with COVID-19, leading to the use of the
term “COVID-19 associated mucormycosis (CAM)”. Treatment of CAM is challenging due to …
term “COVID-19 associated mucormycosis (CAM)”. Treatment of CAM is challenging due to …
Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives.
Y Madhavan, KV Sai, DK Shanmugam… - Journal of Clinical …, 2022 - search.ebscohost.com
Mucormycosis has become increasingly associated with COVID-19, leading to the use of the
term" COVID-19 associated mucormycosis (CAM)". Treatment of CAM is challenging due to …
term" COVID-19 associated mucormycosis (CAM)". Treatment of CAM is challenging due to …
Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives
Y Madhavan, KV Sai… - Journal of clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
Mucormycosis has become increasingly associated with COVID-19, leading to the use of the
term" COVID-19 associated mucormycosis (CAM)". Treatment of CAM is challenging due to …
term" COVID-19 associated mucormycosis (CAM)". Treatment of CAM is challenging due to …
[HTML][HTML] Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives
Y Madhavan, KV Sai, DK Shanmugam… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Mucormycosis has become increasingly associated with COVID-19, leading to the use of the
term “COVID-19 associated mucormycosis (CAM)”. Treatment of CAM is challenging due to …
term “COVID-19 associated mucormycosis (CAM)”. Treatment of CAM is challenging due to …
[PDF][PDF] Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives
Y Madhavan, KV Sai, DK Shanmugam, A Manimaran… - J. Clin. Med, 2022 - academia.edu
Mucormycosis has become increasingly associated with COVID-19, leading to the use of the
term “COVID-19 associated mucormycosis (CAM)”. Treatment of CAM is challenging due to …
term “COVID-19 associated mucormycosis (CAM)”. Treatment of CAM is challenging due to …
[PDF][PDF] Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives
Y Madhavan, KV Sai, DK Shanmugam, A Manimaran… - J. Clin. Med, 2022 - academia.edu
Mucormycosis has become increasingly associated with COVID-19, leading to the use of the
term “COVID-19 associated mucormycosis (CAM)”. Treatment of CAM is challenging due to …
term “COVID-19 associated mucormycosis (CAM)”. Treatment of CAM is challenging due to …